Pier Giorgio Scotton
Pier Giorgio Scotton has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
A. Vaglia
Dept. of Infectious Disease, Cà Foncello Regional Hospital, I-31100 Treviso, Italy; Phone: (+39/0422) 322064, Fax: -2645
2 shared publicationsA Carniato
Divisione di Malattie Infettive, Ospedale Ca' Fondello, Treviso
1 shared publicationA Vaglia
1 shared publicationAlberto Vaglia
Departments of Infectious Diseases, Treviso, Italy
1 shared publication- Claudio Rapezzi
Cardiology, Department of Experimental Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy
1 shared publication - Cristina Nanni
Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
1 shared publication
Latest Publications
- Open Access
- 13 January 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 32
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
The diagnosis of prosthetic valve endocarditis is challenging. The gold standard for prosthetic valve endocarditis diagnosis is trans-esophageal echocardiography. However, trans-esophageal echocardiography may result in negative findings or yield images difficult to differentiate from thrombus in patients with prosthetic valve endocarditis. Combined computed tomography and fluorodeoxyglucose positron emission tomography is a potentially promising diagnostic tool for several infectious conditions and it has also been employed in patients with prosthetic valve endocarditis but data are still scant.
- 13 January 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 32
Open AccessCombined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
The diagnosis of prosthetic valve endocarditis is challenging. The gold standard for prosthetic valve endocarditis diagnosis is trans-esophageal echocardiography. However, trans-esophageal echocardiography may result in negative findings or yield images difficult to differentiate from thrombus in patients with prosthetic valve endocarditis. Combined computed tomography and fluorodeoxyglucose positron emission tomography is a potentially promising diagnostic tool for several infectious conditions and it has also been employed in patients with prosthetic valve endocarditis but data are still scant.
- 2 May 2002
- Published by Springer Nature in Infection
- Vol. 30 (3) , 161-163
Combination of Quinupristin/Dalfopristin and Glycopeptide in Severe Methicillin-Resistant Staphylococcal Infections Failing Previous Glycopeptide Regimens
Background: We report our experience with quinupristin/dalfopristin in combination with a glycopeptide in the treatment of severe staphylococcal infections failing previous glycopeptide regimens. Patients and Methods: Five patients, affected by persistent bacteremia (n = 2), post-cardiothoracic surgery infection (n = 2), and post-traumatic bone infection (n = 1) due to methicillin-resistant Staphylococcus aureus (MRSA, n = 4) methicillin-resistant coagulase-negative Staphylococcus (MRCNS, n = 1) and unsuccessfully treated with antibiotics including a glycopeptide, were treated with a quinupristin/dalfopristin and glycopeptide combination. Results: Three patients were clinically cured; one patient with MRSA thoracic aorta prosthetic infection relapsed after 3 months; one patient was lost to follow-up. Conclusion: Quinupristin/dalfopristin, in combination with a glycopeptide, is an effective treatment option for severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
- 2 May 2002
- Published by Springer Nature in Infection
- Vol. 30 (3) , 161-163
Combination of Quinupristin/Dalfopristin and Glycopeptide in Severe Methicillin-Resistant Staphylococcal Infections Failing Previous Glycopeptide Regimens
Background: We report our experience with quinupristin/dalfopristin in combination with a glycopeptide in the treatment of severe staphylococcal infections failing previous glycopeptide regimens. Patients and Methods: Five patients, affected by persistent bacteremia (n = 2), post-cardiothoracic surgery infection (n = 2), and post-traumatic bone infection (n = 1) due to methicillin-resistant Staphylococcus aureus (MRSA, n = 4) methicillin-resistant coagulase-negative Staphylococcus (MRCNS, n = 1) and unsuccessfully treated with antibiotics including a glycopeptide, were treated with a quinupristin/dalfopristin and glycopeptide combination. Results: Three patients were clinically cured; one patient with MRSA thoracic aorta prosthetic infection relapsed after 3 months; one patient was lost to follow-up. Conclusion: Quinupristin/dalfopristin, in combination with a glycopeptide, is an effective treatment option for severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
- Open Access
- 1 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (9) , e109-e111
Cerebrospinal Fluid Penetration of Levofloxacin in Patients with Spontaneous Acute Bacterial Meningitis
We have assessed levofloxacin penetration in cerebrospinal fluid (CSF) and the liquor-to-plasma ratio (CL/CP) at 2 hours after dosing in 5 patients w
- 1 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (9) , e109-e111
Open AccessCerebrospinal Fluid Penetration of Levofloxacin in Patients with Spontaneous Acute Bacterial Meningitis
We have assessed levofloxacin penetration in cerebrospinal fluid (CSF) and the liquor-to-plasma ratio (CL/CP) at 2 hours after dosing in 5 patients w
- Open Access
- 1 January 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (1) , 223-224
Rhodococcus equi Nosocomial Meningitis Cured by Levofloxacin and Shunt Removal
Rhodococcus equi is increasingly being recognized as a pathogen in immunocompromised patients, especially those infected with HIV. The overwhelming majority of reported R. equi infections in humans involve the lung; CNS infections are rare, occurring as brain abscesses, and meningitis in a healthy host has never been reported [1].
- 1 January 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (1) , 223-224
Open AccessRhodococcus equi Nosocomial Meningitis Cured by Levofloxacin and Shunt Removal
Rhodococcus equi is increasingly being recognized as a pathogen in immunocompromised patients, especially those infected with HIV. The overwhelming majority of reported R. equi infections in humans involve the lung; CNS infections are rare, occurring as brain abscesses, and meningitis in a healthy host has never been reported [1].
- 1 January 1996
- Vol. 4 (3) , 166
[Angioneurotic edema associated to clarithromycin therapy].